Tridihexethyl

This page contains recent news articles, when available, and an overview of Tridihexethyl but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Overview:

Tridihexethyl (when available)

Pharmacology and use:
Tridihexethyl is a synthetic anticholinergic agent which has been shown in experimental and clinical studies to have a pronounced antispasmodic and antisecretory effect on the gastrointestinal tract. Tridihexethyl is an antimuscarinic, anticholinergic drug. Used as an adjunct in the treatment of peptic ulcer disease

Mechanism Of Action:
Tridihexethyl binds the muscarinic acetylcholine receptor. It may block all three types of muscarinic receptors including M-1 receptors in the CNS and ganglia, M-2 receptors in the heart (vagus) and M-3 receptors at the parasympathetic NEJ system. The muscarinic acetylcholine receptors mediate various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Tridihexethyl inhibits vagally mediated reflexes by antagonizing the action of acetylcholine. This in turn reduces the secretion of gastric acids in the stomach.

News Articles on Tridihexethyl

Brand Names/Synonyms:
Tridihexethyl is also known by the following brand names and/or synonyms:
Pathilon; Propethonum; Tridihexethyl; Tridihexethyl Chloride

Drug Category:
Tridihexethyl is categorized under the following by the FDA: Antispasmodics; Anticholinergic Agents; ATC:A03AB08

Dosage Forms:
TABLETS; CAPSULES

Absorption:
Not Available

Interactions:
Not Available

Chemical IUPAC Name:
(3-cyclohexyl-3-hydroxy-3-phenyl-propyl)-triethyl-ammonium

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.